Drawing for NEW DAY BIORESEARCH

USPTO serial 98691539

NEW DAY BIORESEARCH

Reviewed by CopyMark Law Group

Reg. 7815113Status 700Registered
Filing date
Status date
Registration date
Jun 3, 2025
Examiner
SWAIN, MICHELE LYNN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NEW DAY BIORESEARCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephen P. McNamara

Stephen P. McNamara St. Onge Steward Johnston & Reens LLC857 Post Road, Ste 398Fairfield, CT 06824-6041United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for approval of diagnostic devices, therapeutic devices, and drugs; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approvalACTIVEJul 2, 2024
042Clinical research in the field of diagnostic devices and diagnostic preparations; Consulting services for others in the field of design, planning, and implementation project management of clinical studies of diagnostic devices, therapeutic devices, and drugs; Medical and scientific research, namely, conducting clinical trials for others; Product development consulting in the field of diagnostic devices, therapeutic devices, and drugs; Providing information about medical research in the field of diagnostic devices, therapeutic devices, and drugs; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of diagnostic preparations; Scientific research in the nature of conducting clinical trials for others in the field of diagnostic devices, therapeutic devices, and drugsACTIVEJul 2, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 3, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 3, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 15, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 15, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 9, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 21, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 24, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 24, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 24, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 24, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 18, 2025DOCKASSIGNED TO EXAMINER—
Jan 22, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 9, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance